Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Epidermolysis Bullosa - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the market size of epidermolysis bullosa was highest in the US among the 7MM, accounting for approximately USD 1,300 million, which is further expected to increase by 2034. Epidermolysis bullosa simplex (EBS) is the least severe type of epidermolysis bullosa, and many individ ... Read More
-
Acromegaly- Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights According to the estimates, the Acromegaly market size in the 7MM is ~USD 1,300 million in 2023. In 2023, among all the therapies, the highest Acromegaly market revenue was generated by somatostatin, i.e., ~USD 300 million, followed by growth hormone antagonist, i.e., ~USD 90 million ... Read More
-
Ewing Sarcoma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the US accounted for the maximum share of the Ewing sarcoma Treatment Market in the 7MM, i.e., nearly 53%. A molecular-targeted therapy with minimal risk of late toxicities would be beneficial because most Ewing sarcoma Patients are under 20 years old. Although there is no st ... Read More
-
Chronic Spontaneous Urticaria - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s analysis, the Chronic Spontaneous Urticaria Market Size in the 7MM was valued at approximately USD 2,173.3 million in 2023. Over the forecast period from 2024 to 2034, this market is projected to grow at a CAGR of more than 10%, driven by the introduction o ... Read More
-
Advanced Melanoma - Pipeline Insight, 2025
DelveInsight’s, “Advanced Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Inclusion Body Myositis- Pipeline Insight, 2025
DelveInsight’s, “Inclusion Body Myositis- Pipeline Insight, 2025” report provides comprehensive insights about 2+ companies and 3+ pipeline drugs in Inclusion Body Myositis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More
-
Dry Eye Disease - Pipeline Insight, 2025
DelveInsight’s, “Dry Eye Disease - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Dry Eye Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Ocular Hypertension - Pipeline Insight, 2025
DelveInsight’s, “Ocular Hypertension - Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Ocular Hypertension pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Tie-2 Receptor Inhibitor - Pipeline Insight, 2025
“Tie-2 Receptor Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Tie-2 Receptor Inhibitor development. The report provides detailed coverage of the pipeline landscape for thi ... Read More
-
Serotonin Transporter Inhibitor - Pipeline Insight, 2025
“Serotonin Transporter Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Transporter Inhibitor development. The report provides detailed coverage of the pipeline lan ... Read More
-
Potassium Channel Openers - Pipeline Insight, 2025
“Potassium Channel Openers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Potassium Channel Openers development. The report provides detailed coverage of the pipeline landscape for t ... Read More
-
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025
“Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Kv1.3/1.5 Potassium Channel Blockers development. The report provides detailed coverage of the pi ... Read More
-
Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025
“Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-1 (IL-1) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More
-
Factor IX - Pipeline Insight, 2025
DelveInsight’s, “Factor IX - Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Factor IX pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by ... Read More
-
Arginine Depletors - Pipeline Insight, 2025
“Arginine Depletors - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Arginine Depletors development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Angiotensin Modulators - Pipeline Insight, 2025
“Angiotensin Modulators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Modulators development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Angiopoietin Inhibitor - Pipeline Insight, 2025
“Angiopoietin Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiopoietin Inhibitor development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Alpha-Amylase Inhibitor - Pipeline Insight, 2025
“Alpha-Amylase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-Amylase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this ... Read More
-
Alpha-2 Agonist - Pipeline Insight, 2025
“Alpha-2 Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-2 Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of act ... Read More
-
Alpha-2 Antagonist - Pipeline Insight, 2025
“Alpha-2 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-2 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Alpha-1A Antagonist - Pipeline Insight, 2025
“Alpha-1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Alpha Receptor Antagonist - Pipeline Insight, 2025
“Alpha Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha Receptor Antagonist development. The report provides detailed coverage of the pipeline landscape for t ... Read More
-
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Antagonist development. The report provides detailed coverage of the pipeline ... Read More
-
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A3 Receptor Antagonist development. The report provides detailed coverage of the pipeline l ... Read More
-
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2 Receptor Antagonist development. The report provides detailed coverage of the pipeline l ... Read More
Research Assistance
